Grundy SM, Vega GL, McGovern ME, et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Arch Intern Med. 2002;162:1568-1576.
Elam MB, Hunninghake DB, Davis KB, et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients With diabetes and peripheral arterial disease. The ADMIT Study: a randomized trial.
JAMA. 2000;284:1263 - 1270.
Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Diabetes Care. 2000;23:1407 - 1415.
Kagan VE, Shvedova A, Serbinova E, et al. Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase.
Biochem Pharmacol. 1992;44:1637 - 1649.
Hounsom L, Horrobin DF, Tritschler H, et al. A lipoic acid - gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
Diabetologia. 1998;41:839 - 843.
Cameron NE, Cotter MA, Horrobin DH, et al. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.
Diabetologia. 1998;41:390 - 399.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid. (ALADIN III Study). ALADIN III Study Group.
Diabetes Care. 1999;22:1296 - 301.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes. 1997;46(suppl 2):S62 - S66.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Diabetologia. 1995;38:1425 - 1433.
Kahler W, Kuklinski B, Ruhlmann C, et al. Diabetes mellitus - a free radical-associated disease. Results of adjuvant antioxidant supplementation [in German; English abstract].
Z Gesamte Inn Med. 1993;48:223 - 232.
Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant.
Free Radic Biol Med. 1995;19:227 - 250.
Ruhnau KJ, Meissnert HP, Finn JR, et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
Diabet Med. 1999;16:1040 - 1043.
Stevens EJ, Lockett MJ, Carrington AL, et al. Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus.
Diabetologia. 1993;36:397 - 401.
Reichert RG. Evening primrose oil and diabetic neuropathy.
Q Rev Natr Med.1995;129 - 133.
Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group.
Diabetes Care. 1993;16:8 - 15.
Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
Diabet Med. 1990;7:319 - 323.
Turpeinen AK, Kuikka JT, Vanninen E, et al. Long-term effect of acetyl-L-carnitine on myocardial 123I-M IBG uptake in patients with diabetes.
Clin Auton Res. 2000;10:13 - 16.
Manzella D, Barbieri M, Ragno E, et al. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes.
Am J Clin Nutr. 2001;73:1052 - 1057.
Bursell SE, Clermont AC, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care. 1999;22:1245 - 1251.
Tutuncu NB, Baraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes.
Diabetes Care. 1998;21:1915 - 1918.
Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Diabetes Care. 2002;25:1919 - 1927.
Salway JG, Finnegan JA, Barnett D, et al. Effect of myo-inositol on peripheral-nerve function in diabetes.
Lancet. 1978;2:1282 - 1284.
Gregersen G, Bertelsen B, Harbo H, et al. Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals.
Acta Neurol Scand. 1983;67:164 - 172.
Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats.
J Nutr. 1999;129:207 - 213.
Incandela L, Cesarone MR, DeSanctis MT, et al. Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study.
J Cardiovasc Pharmacol Ther. 2002;7(Suppl 1):S11 - S15.
Bravetti G. Preventive medical treatment of senile cataract with vitamin E and Vaccinium myrtillus anthocyanosides: clinical evaluation.
Ann Ottalmol Clin Ocul. 1989;115:109 - 116.
Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies [translated from German].
Klin Monatsbl Augenheilkd. 1981;178:386 - 389.
Schonlau F, Rohdewald P. Pycnogenol for diabetic retinopathy. A review.
Int Ophthalmol. 2001;24:161 - 171.
Will JC, Byers T. Does diabetes mellitus increase the requirement for vitamin C?
Nutr Rev. 1996;54:193 - 202.
Mullan BA, Young IS, Fee H, et al. Ascorbic Acid reduces blood pressure and arterial stiffness in type 2 diabetes.
Hypertension. 2002;40:804 - 809.
Ajiboye R, Harding JJ. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione.
Exp Eye Res. 1989;49:31 - 41.
Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Diabetes Care. 2003;26:770 - 776.
Weintraub M. Magnetic bio-stimulation in painful diabetic peripheral neuropathy: a novel intervention-a randomized, double-placebo crossover study.
Am J Pain Manag. 1999;9:8 - 17.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.